Pfizer Is ‘Mutating’ Viruses, Exploring ‘Directed Evolution’ of COVID to ‘Preemptively Develop Future Vaccines’ (Video)

A new video released by Project Veritas on Wednesday exposes Pfizer executive Jordon Trishton Walker, who claims that his company is exploring a way to “mutate” the coronavirus via “Directed Evolution.”

Walker, who is the Director of Research and Development, Strategic Operations, and mRNA Scientific Planner at Pfizer, claims that his company is probing this method to “preemptively develop new vaccines.”

The Pfizer executive even acknowledges that the public would be upset after learning about the company’s actions.

“One of the things we’re exploring is like, why don’t we just mutate [COVID] ourselves so we could create—preemptively develop new vaccines, right? So, we have to do that. If we’re gonna do that though, there’s a risk of like, as you could imagine—no one wants to be having a pharma company mutating [expletive] viruses,” Walker says in the video.

He goes on to say that Pfizer scientists are “optimizing” the COVID mutation process but are moving slowly in order to conceal their work.

Walker says the scientists “are optimizing [the COVID mutation process], but they’re going slow because everyone is very cautious—obviously they don’t want to accelerate it too much. I think they are also just trying to do it as an exploratory thing because you obviously don’t want to advertise that you are figuring out future mutations.”

The executive also states that Pfizer is conducting this research in controlled environments with live monkeys.

“Don’t tell anyone. Promise you won’t tell anyone. The way [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them,” he says.

The research director also mentions that COVID has been instrumental for Pfizer’s recent business success and that the company sees the virus as a “cash cow.”

“Some of the times there are mutations that pop up that we are not prepared for,” he says. “Like with Delta and Omicron. And things like that. Who knows? Either way, it’s going to be a cash cow. COVID is going to be a cash cow for us for a while going forward. Like obviously.”

Walker also discusses the “revolving door” between big pharma companies and government officials, admitting that such a business model is good for the industry but bad for the American people.

Big pharmaceutical companies maintain a “revolving door for all government officials,” he says, adding that “all the people who review our drugs—eventually most of them will come work for pharma companies. And in the military, defense government officials eventually work for defense companies afterwards.”

“How do you feel about that revolving door?” the undercover journalist asks Walker.

“It’s pretty good for the industry to be honest. It’s bad for everybody else in America,” the Pfizer official says.

“Why is it bad for everybody else?” the journalist asks.

“Because when the regulators reviewing our drugs know that once they stop regulating, they are going to work for the company, they are not going to be as hard towards the company that’s going to give them a job,” Walker answers.